Drug Profile
Research programme: dermatologic disorder therapeutics - Takeda
Latest Information Update: 28 Oct 2020
Price :
$50
*
At a glance
- Originator Takeda Pharma
- Class Skin disorder therapies; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Skin disorders